VanEck Pharmaceutical ETF
48 hedge funds and large institutions have $40.9M invested in VanEck Pharmaceutical ETF in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
2.08% less ownership
Funds ownership: 17.35% → 15.27% (-2.1%)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.8M | |
| 2 | +$814K | |
| 3 | +$313K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$311K |
| 5 |
CCT
Country Club Trust
Kansas City,
Missouri
|
+$201K |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$899K | |
| 3 | -$598K | |
| 4 |
AWM
Altavista Wealth Management
Asheville,
North Carolina
|
-$201K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$176K |